Back to Mediolanum International Funds Ltd

REGN
Showing 8 of 9 quarters

Position history for Mediolanum International Funds Ltd's holdings in REGENERON PHARMACEUTICALS

Mediolanum International Funds Ltd holds 71,209 shares of REGN (REGENERON PHARMACEUTICALS), worth $53.4M as of 2026-Q1. The position was increased (+56.4% shares). REGN represents 0.6% of Mediolanum International Funds Ltd's portfolio.

Current Value

$53.4M

Current Shares

71,209

Total Value Change

+$38.9M

Total Shares Change

+56,467

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
71,209
+56.4%
$53.4M0.6%$766.66
59
2025-Q4
Increased
45,535
+3528.3%
$35.2M0.4%$773.94
56
2025-Q3
Decreased
1,255
-65.0%
$703,7410.0%$560.05
0
2025-Q2
Decreased
3,591
-89.2%
$1.9M0.0%$519.56
0
2025-Q1
Increased
33,220
+646.7%
$21.2M0.3%$634.66
55
2024-Q4
Increased
4,449
+5.3%
$3.1M0.0%$698.71
28
2024-Q3
Decreased
4,225
-71.3%
$4.4M0.1%$1,036.94
0
2024-Q2
Increased
14,742
+14.6%
$14.5M0.2%$1,045.23
38

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used